MAP
Madison Avenue Partners Portfolio holdings
AUM
$1.5B
1-Year Return
26.66%
This Quarter Return
+4.67%
1 Year Return
+26.66%
3 Year Return
+137.23%
5 Year Return
+278.64%
10 Year Return
–
AUM
$1.5B
AUM Growth
+$320M
(+27%)
Cap. Flow
+$282M
Cap. Flow
% of AUM
18.81%
Top 10 Holdings %
Top 10 Hldgs %
83.78%
Holding
30
New
8
Increased
6
Reduced
8
Closed
4
Top Buys
| 1 |
SNDK
Sandisk Corporation Common Stock
SNDK
|
+$162M |
| 2 |
Globus Medical
GMED
|
+$101M |
| 3 |
Galapagos
GLPG
|
+$52.5M |
| 4 |
Keros Therapeutics
KROS
|
+$35.9M |
| 5 |
MRP
Millrose Properties, Inc.
MRP
|
+$23.5M |
Top Sells
| 1 |
PG&E
PCG
|
+$50.7M |
| 2 |
Solventum
SOLV
|
+$43.1M |
| 3 |
Markel Group
MKL
|
+$14.1M |
| 4 |
Nelnet
NNI
|
+$10.9M |
| 5 |
SLRN
ACELYRIN
SLRN
|
+$10.2M |
Sector Composition
| 1 | Healthcare | 44.49% |
| 2 | Consumer Staples | 15.49% |
| 3 | Financials | 12.41% |
| 4 | Technology | 10.81% |
| 5 | Communication Services | 8.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Graham Holdings Company
GHC
$4.97B
| $232M | 15.49% |
245,271
| – | – |
|
|
2
Solventum
SOLV
$12.9B
| $170M | 11.36% |
2,244,344
-568,673
| -20% | -$43.1M |
|
|
3
Markel Group
MKL
$24.4B
| $168M | 11.24% |
84,310
-7,047
| -8% | -$14.1M |
|
|
SNDK
4
Sandisk Corporation Common Stock
SNDK
$10.3B
| $162M | 10.81% |
+3,571,109
| New | +$162M |
|
5
Indivior
INDV
$3.09B
| $117M | 7.8% |
7,922,178
+130,089
| +2% | +$1.92M |
|
6
Theravance Biopharma
TBPH
$701M
| $105M | 7% |
9,511,150
| – | – |
|
|
7
Globus Medical
GMED
$8.04B
| $101M | 6.75% |
+1,712,148
| New | +$101M |
|
8
John Wiley & Sons Class A
WLY
$2.21B
| $91.6M | 6.12% |
2,052,696
-155,370
| -7% | -$6.93M |
|
|
SAGE
9
DELISTED
Sage Therapeutics
SAGE
| $55.4M | 3.7% |
6,077,065
+1,599,267
| +36% | +$14.6M |
|
|
10
Galapagos
GLPG
$2.21B
| $52.5M | 3.51% |
+1,877,011
| New | +$52.5M |
|
|
MAGN
11
Magnera Corporation
MAGN
$420M
| $40.4M | 2.7% |
3,344,005
| – | – |
|
12
Stagwell
STGW
$1.43B
| $36.1M | 2.41% |
8,014,322
+866,660
| +12% | +$3.9M |
|
|
13
Keros Therapeutics
KROS
$628M
| $35.9M | 2.4% |
+2,691,465
| New | +$35.9M |
|
|
INVX
14
Innovex International, Inc.
INVX
$1.14B
| $27.6M | 1.84% |
1,767,997
-645,611
| -27% | -$10.1M |
|
|
MRP
15
Millrose Properties, Inc.
MRP
$5.69B
| $23.5M | 1.57% |
+825,804
| New | +$23.5M |
|
|
16
Nelnet
NNI
$4.58B
| $17.5M | 1.17% |
144,214
-89,616
| -38% | -$10.9M |
|
|
CRGX
17
DELISTED
CARGO Therapeutics
CRGX
| $17.3M | 1.15% |
4,193,626
+4,092,674
| +4,054% | +$16.9M |
|
18
Cannae Holdings
CNNE
$1.09B
| $14.1M | 0.94% |
674,250
+255,266
| +61% | +$5.32M |
|
|
AIV
19
Aimco
AIV
$1.1B
| $12.7M | 0.85% |
+1,473,826
| New | +$12.7M |
|
|
ALMS
20
Alumis Inc. Common Stock
ALMS
$450M
| $5.53M | 0.37% |
+1,842,269
| New | +$5.53M |
|
|
FSP
21
Franklin Street Properties
FSP
$175M
| $4.23M | 0.28% |
2,580,357
-153,061
| -6% | -$251K |
|
22
Arvinas
ARVN
$583M
| $3.68M | 0.25% |
+500,000
| New | +$3.68M |
|
23
Pliant Therapeutics
PLRX
$106M
| $2.59M | 0.17% |
2,230,012
+554,969
| +33% | +$644K |
|
24
Columbus McKinnon
CMCO
$428M
| $702K | 0.05% |
45,961
-573,382
| -93% | -$8.76M |
|
25
SharkNinja
SN
$16.2B
| $609K | 0.04% |
6,152
| – | – |
|